BUNICK, C.; BHATIA, N.; DEL ROSSO, J.; DRAELOS, Z.; EICHENFIELD, L.; KIRCIK, L.; LEBWOHL, M.; GOODERHAM, M.; GREEN, L.; HEBERT, A.; VENDER, R.; ZIRWAS, M.; SIMPSON, E.; STEIN GOLD, L.; SEAL, M.; SNYDER, S.; OSBORNE, D.; BURNETT, P.; HIGHAM, R.; CHU, D.; BERK, D. Investigator- and Patient-Rated Local Tolerability in Phase 3 Trials of Topical Roflumilast in Patients With Psoriasis, Seborrheic Dermatitis, and Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s309, 2024. DOI: 10.25251/skin.8.supp.309. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2540. Acesso em: 3 jul. 2024.